Easton Pharmaceuticals Inc EAPH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.02
- Market Cap
- $1,344.93
- Volume/Avg
- 11,998 / 14,100
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 6
Valuation
|
Metric
|
EAPH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
EAPH
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
EAPH
Profitability
|
Metric
|
EAPH
|
|---|---|
Return on Assets (Normalized) | −1.38% |
Return on Equity (Normalized) | −2.69% |
Return on Invested Capital (Normalized) | −1.51% |
Return on Assets
EAPH
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Bzhqnnwmpx | Lkpf | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Mtnmfwffr | Ymwzpj | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Gstzmsmsv | Xhyp | $41.4 Bil | |||
| Viatris Inc
VTRS
| Dshjscwys | Sbnk | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Bppzqpll | Skhr | $13.7 Bil | |||
| Catalent Inc
CTLT
| Rqlsswngs | Zrdrjd | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Sklskqf | Plqvm | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Bxsklsvyg | Ddmpwnh | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Ztgcftj | Gscz | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Bpclpghvbl | Bwgx | $2.7 Bil |